Japan myocardial infarction market is estimated to grow modestly at a CAGR of around 7.0% during the forecast period. The growth of the myocardial infarction market in Japan is being supported by innovative and advanced product launches by the key regional market players. The geriatric population is one of the major concerns for the Japanese government and other healthcare institutions in the country. As per the UN, out of the total 126 million population, about 27% population of the country was above 65 years in 2019.

The possibility of a heart attack in the geriatric population is relatively high as compared to the young population. As per the Institute for Health Metrics and Evaluation, the country is witnessing a modest growth in the cases related to CVD. In 2014, 3.40 million new cases of CVD were witnessed in the country which was slightly increased to 3.54 million in 2017.

Request a Free Sample of our Report on Japan Myocardial Infarction Market: https://www.omrglobal.com/request-sample/japan-myocardial-infarction-market

The market is segmented into type, device, diagnosis, treatment, and end-user. Based on type, the market is segmented into ST-elevation myocardial infarction (STEMI) heart attacks, non-ST elevation myocardial infarction (NSTEMI) heart attacks, and silent heart attacks.

Based on the device, the market is segmented into a left ventricular assist device, pacemaker, implantable cardioverter defibrillator, and others (aspiration-based catheters). Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest X-Ray, Computed Tomography (CT Scan), echocardiography, and others (blood test). Based on treatment, the market is segmented into medication and surgery. Based on end-user, the market is segmented into hospitals & clinics, Ambulatory Surgical Centers (ASCs), and research institutes.

A Full Report of Japan Myocardial Infarction Market is Available at https://www.omrglobal.com/industry-reports/japan-myocardial-infarction-market

Japan Myocardial Infarction Market

By Type
• Non-ST-elevation myocardial infarction (NSTEMI)
• ST-elevation myocardial infarction (STEMI)
• Silent Heart Attacks

By Device
• Left Ventricular Assist Device (LVAD)
• Pacemaker
• Catheters
• Implantable Cardioverter-Defibrillator (ICD)
• Others (Stent Graft)

By Diagnosis
• Electrocardiography (ECG)
• Chest X-Ray
• Computed Tomography (CT Scan)
• Echocardiography
• Others (Blood Test)

By Treatment
• Medication
o Analgesics
o Thrombolytic
o Antiplatelet Agents
o Glycoprotein IIb/IIIa Inhibitors
o Others (Beta-Adrenergic Blockers)
• Surgery
o Angioplasty
o Bypass Surgery
o Heart Transplant

By End-User
• Hospital & Clinics
• Ambulatory Surgical Centers
• Research Institutes

Company Profiles
• Abbott Laboratories Inc.
• AstraZeneca PLC
• Bayer AG
• Boston Scientific Corp.
• Bristol-Myers Squibb Co.
• Eli Lilly and Co.
• GlaxoSmithKline Plc
• Johnson & Johnson Services, Inc.
• Medtronic PLC
• Merck KGaA
• Mylan N.V.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/turret-system-market

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404